Loading data...
BioPhenoMA Inc.
CEO
Naoto Fujii
N/A
Recent News & PR
Summary
Message to Participants
Detailed Information
BioPhenoMA Inc. aims to contribute to advancements in the biomedical field by providing an innovative platform that allows for the easy detection and quantification of trace proteins. Using our unique TN-cyclon™ technology, we create a new research infrastructure that analyzes protein dynamics while maintaining the structure derived from biological sources.
Unfair Advantage & Strengths
N/A
Competitors
N/A
Company Profile
事業カテゴリ
DeepTech, Healthcare / Biotech, Hardware / Robotics / IoT
本社所在地
1-22-3 Nishiwaseda, Shinjuku-ku, Tokyo, Waseda University Entrepreneurship Center
設立日
2024年4月18日
資本金
197,000,911 JPY
Employee Count
3名
Industry Outlook & Trends for BioPhenoMA Inc.
Driven by aging populations and rising healthcare costs, the healthcare and biotech market where BioPhenoMA Inc. operates is growing globally. Telemedicine, digital health via wearables, AI-driven drug discovery, and gene therapy are advancing rapidly. The industry is shifting from treatment to prevention, increasing demand for highly personalized health solutions like those developed by BioPhenoMA Inc..
🔒
VPO Investor Pro Features
You are viewing a basic startup profile. Create a free account to access the dashboard. You can also upgrade to the "Investor Pro" plan to unlock full access to the following premium databases and features:
🎬
Elevator & Full Pitch Video
Watch full presentations with English/Japanese subtitles.
📊
AI Quick Report & Valuation
Get AI-driven assessment scores on market, product, and traction.
📅
Priority Challenges & Hiring
Access core corporate bottlenecks and current hiring plans.
📝
Full Transcripts
Read full pitch dialogue in both English and Japanese.
📈
Financials & Exit Strategy
Unlock IPO/M&A timelines and debt/equity plans.
👥
Advisors & Key Members
View internal team details and advisory board configurations.